Epilepsy, progessive movement disorder and cognitive decline.
Robertson
B
B
Neuropsychiatry Unit, Melbourne Neuropsychiatry Centre, University of Melbourne and North-Western Mental Health, Royal Melbourne Hospital, Parkville, Melbourne, Victoria 3052, Australia. brent.robertson@mh.org.au
Evans
A H
AH
Walterfang
M
M
Ng
A P
AP
Velakoulis
D
D
D000328:Adult; D001284:Atrophy / Q000209:etiology / Q000473:pathology; D001480:Basal Ganglia Diseases / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D003072:Cognition Disorders / Q000209:etiology*; D015897:Comorbidity; D003937:Diagnosis, Differential; D018450:Disease Progression; D004827:Epilepsy / Q000209:etiology*; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D008279:Magnetic Resonance Imaging; D009069:Movement Disorders / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D009154:Mutation / Q000235:genetics; D054546:Neuroacanthocytosis / Q000150:complications* / Q000175:diagnosis* / Q000503:physiopathology; D011379:Prognosis; D033921:Vesicular Transport Proteins / Q000235:genetics
C429654:VPS13A protein, human; D033921:Vesicular Transport Proteins